RxRevu, Inc. — Form D
RxRevu, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-17. The offering totals $10.0M, of which $6.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-01-17
- Form: D
- Accession: 0001604586-23-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $6.0M
- Remaining: $4.0M
- Investors: 1
- Date of first sale: 2022-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470936
Issuer
- Name: RxRevu, Inc.
- CIK: 0001604586
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 3001 Brighton Blvd., Suite 103, DENVER, CO, 80216
- Phone: 800-360-4965
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Toby Cosgrove | Director | Mountain View, CA |
| Andrew Firlik | Director | Rowayton, CT |
| Daniel Galles | Director | Seattle, WA |
| Kyle Kiser | Director | DENVER, CO |
| STEVE LINDSETH | Director | LEWES, DE |
| Stephen McHale | Director | Willowick, OH |
| ALBERT PRAST | Director | LEWES, DE |
| Richard Zane | Director | Long Island City, NY |
| Benton Barney | Executive Officer | Englewood, CO |
| Christie Callahan | Executive Officer | DENVER, CO |
| Aaron Cornell | Executive Officer | DENVER, CO |
| Kyle Kiser | Executive Officer | DENVER, CO |
| STEVE LINDSETH | Executive Officer | LEWES, DE |
| Lew Parker | Executive Officer | DENVER, CO |
| Kevin Carmody O'Brien | Director | Denver, CO |
| Kevin Carmody O'Brien | Executive Officer | Denver, CO |
| Daniel Carmody Caron | Executive Officer | Denver, CO |
| Steve Carmody Lindseth | Director | Denver, CO |
| David Carmody Huntress | Director | Denver, CO |
| David Carmody Huntress | Executive Officer | Denver, CO |
| Jeffrey Carmody Patton | Director | Denver, CO |
Other filings by this issuer (5)
More